Recombinant CALCRL (Erenumab Biosimilar) antibody
The Human Monoclonal anti-CALCRL (Erenumab Biosimilar) antibody has been validated for ELISA and WB. It is suitable to detect CALCRL (Erenumab Biosimilar) in samples from Human.
Catalog No. ABIN7538073
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant CALCRL (Erenumab Biosimilar) antibody (ABIN7538073)
Target
CALCRL (Erenumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CALCRL (Erenumab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Erenumab Biosimilar – Anti-CALCRL mAb - Research Grade
-
Characteristics
- Antibody Type: IgG2-lambda
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG2 lambda
-
-
anti-CALCRL (Erenumab Biosimilar) antibody
Research Grade Reactivity: Human FACS Host: Human Monoclonal unconjugated
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CALCRL (Erenumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.
-
CAS-No
- 1582205-90-0
Target
-
You are here:
